This edition of the companion volumes Muscle Pain: Understanding the Mech- isms and Muscle Pain: Diagnosis and Treatment is essential reading for those interested in clinical approaches to acute and chronic pain conditions involving muscle tissues and in the mechanisms underlying these conditions. The volumes cover a very important topic in pain medicine, since muscle pain is very common and can often be dif?cult to diagnose and treat effectively. Furthermore, chronic pain involving muscle and other components of the musculoskeletal system increases with age, such that it is a common complaint of those of us who are middle-aged or older. Indeed, as changing population demographics in "west- nized" countries result in higher proportions of the population living longer and being middle-aged and elderly, chronic muscle pain will likely become even more of a health problem. In the case of acute muscle pain, this can often be very intense, and in the short term can limit or modify the use of components of the musculoskeletal system associated with the sensitive muscle. Chronic muscle pain can also be intense, as well as unpleasant and disabling, and it is in many cases the over-riding symptom of most musculoskeletal disorders that are associated with long-term deleterious changes in musculoskeletal function.

nd This book stems from the 2 Parkinson's Disease Symposium on "Neurotoxic Factors in Parkinsons disease and related disorders," held on August 6-7,1999 at the University ofUlm Medical School in Ulm at the Danube, Germany. The symposium wasalso asatellite ofthejointmeetingofthe InternationalSocietyfor Neurochemistry (ISN) and the European Society for Neurochemistry (ESN) that followed immediately afterwards in Berlin. The specific topic, neurotoxic factors in Parkinson's disease (PD), was chosen in light of accumulating neurobiological and epidemiological evidence indicating that the causes of this second most common neurodegenerative disorder, and possibly of related conditions such as multiple systems atrophy, in some manner involve environ mental (xenobiotic) and even endogenous toxic agents. This volume brings together much of that neurobiological evidence; and in epidemiology, several recent major studies ofPD - for example, a study of20,000 twins published in the Journal of the American Medical Association in 1999 - conclude that environmental and life style than genetics, appear to be critical in the idiopathic disease. However, factors, rather the precise roles of neurotoxic factors in the pathogenesis of PD and related basal ganglia disorders remain uncertain, despite the cascade of research resulting from the discovery of the prototype MPTP in the early 1980's, and frankly, we have been surprised by the paucity of concentrated attention on specific environmental agents other than MPTP."

By 2010, 15% of the U.S. population will be Hispanic. "Neuropsychology and the Hispanic Patient: A Clinical Handbook" brings together internationally recognized authorities to address the cultural, methodological, research, and forensic issues that must be considered by neuropsychologists seeking to be maximally effective in their work with members of the fastest-growing American minority group. It includes:
* useful assessment decision trees;
* summaries of normative data;
* descriptions of tests available in Spanish;
* extensive HIV and pediatric references; and
* numerous charts and illustrations.
Reflecting the latest demographic information and covering the developmental spectrum from pediatric to geriatric, this landmark "Handbook" will become an indispensable reference tool for clinicians and researchers alike.

Epilepsy surgery is defined as any neurosurgical intervention whose pri- mary objective is to relieve medically intractable epilepsy (European Fed- eration of Neurological Societies Task Force 2000). The aim of epilepsy surgery is to reduce the number and intensity of seizures, minimise neuro- logical morbidity and antiepileptic drug (AED) toxicity, and improve quality of life. By definition, epilepsy surgery does not include normal surgical treatment of intracranial lesions where the primary goal is to di- agnose and possibly remove the pathological target, often an advancing tumour. In these patients, epileptic seizures are only one symptom of the lesion and will be treated concomitantly as part of the procedure. Temporal lobe epilepsy (TLE) is recognised as the most common type of refractory, focal epilepsy. In one third of all cases the neuronal systems responsible for the seizures that characterise this form of epilepsy fail to respond to currently available AEDs (Andermann F 2002). New imaging methods, especially magnetic resonance imaging (MRI), identify localising abnormalities in an increasing proportion of patients with intractable focal epilepsy. Consequently, the accuracy of the preoperative diagnostic pro- cedures has been significantly improved during the last decade; and suit- able candidates for surgery can be selected more reliably. Currently the main resources in most epilepsy surgery centres have been used to evaluate candidates for TLE surgery.

Dr Jennifer Bute is in considerable demand as a speaker, and has been the subject of a number of features in the press and the electronic media. She is comfortable with being interviewed.

Now in its revised, updated Second Edition, this pocket-sized handbook is a practical quick-reference guide to the diagnosis and management of neurologic diseases. It presents specific management recommendations in a succinct outline format and includes protocols, step-by-step tests and procedures, and treatment algorithms.

This handbook is unique in its inclusion of material from related disciplines such as general medicine, cardiology, psychiatry, neurosurgery, neuroanatomy, and radiology. The authors offer guidance in using contemporary neuroimaging techniques in diagnosis.

In August of 1991, a second Dartmouth International Workshop on the corpus callosum was convened to share and discuss the progress that had been made over the decade that had passed following the first workshop. A nucleus of basic and clinical scientists came together to discuss their work and the work of others in a field that has been broadened clinically by the addition of many new centers throughout the world that are now performing corpus callosotomy for intractable epilepsy. This text was stimulated by the participants' presentations and associated fertile discussions. It is compiled from the conference and subsequent studies. It reflects, both at the basic and clinical level, an important and expanding field of neural science endeavor. In keeping with the present and rapidly expanding field of outcomes assessment, callosotomy is again evaluated in light of a further decade of surgery and follow-up. Callosotomy continues to be a useful, palliative procedure and the indications for its use have been better established. The basic science section is a supplement to the first edition and elaborates progress in both new data and ideas. The section on experimental epilepsy models adds further support to the clinical rationale for callosotomy. Perhaps of greater importance is the contribution of experimental models to our understanding of the propagation of seizure activity. The section on the neuropsychology of the split brain patient demonstrates the continuing major contributions to the understanding of brain and behavior that pour forth from this cornucopia.

Preface:

To understand Alzheimera (TM)s disease (AD) is one of the major thrusts of present-day clinical research, strongly supported by more fundamental cellular, biochemical, immunological and structural studies. It is these latter that receive attention within this book. This compilation of 20 chapters indicates the diversity of work currently in progress and summarizes the current state of knowledge. Experienced authors who are scientifically active in their fields of study have been selected as contributors to this book, in an attempt to present a reasonably complete survey of the field. Inevitably, some exciting topics for one reason or another have not been included, for which we can only apologize.

Standardization of terminology is often a problem in science, not least in the Alzheimer field; editorial effort has been made to achieve standardazation between the Chapters, but some minor yet acceptable personal / author variation is still present, i.e. A-amyloid/amyloid-A; AA42/AA1-42/AA1-42!

The book commences with a broad survey of the contribution that the range of available microscopical techniques has made to the study of Alzheimera (TM)s amyloid plaques and amyloid fibrillogenesis. This chapter also serves as an Introduction to the book, since several of the topics introduced here are expanded upon in later chapters. Also, it is significant to the presence of this chapter that the initial discovery of brain plaques, by Alois Alzheimer, utilized light microscopy, a technique that continues to be extremely valuable in present-day AD research. Then follow 19 further chapters dealing with interesting areas of research that have a bearing upon Alzheimera (TM)sdisease. The authors present their own data within the context of a review of related work from others in their field of study.

Transgenic mouse models for AD are increasingly important and widely used, as is the understanding of the enzymology and biochemistry of amyloid A production from the amyloid precursor protein (APP) by the A- and g -secretases, and the non-amyloidogenic APP cleavage products due to a -secreatases. Similarly, discussion of the enzymes responsible for the natural degradation of amyloid-A is included. Oxidative stress in AD and the possible protective role of vitamin E have emerged as highly significant topics. Likewise, the role of the metals, aluminium copper and zinc in AD is thoroughly addressed, along with the possible value of metal chelation. Current concepts as to the fundamental importance of amyloid-A oligomers versus AA fibrillar deposits (diffuse and senile plaques) in the pathogenesis of AD is presented, along with the likely role of tissue and cellular cholesterol in the promotion of AA fibrillogenesis, and Congo red binding to AA fibrils.

Several naturally occurring human proteins have the ability to bind to AA and are found in AD diffuse and senile plaques. Apolipoprotein E4, clusterin (ApoJ) and acetylcholinesterase are considered in depth. The direct effects of AA on neuronal membranes, in terms of neuronal membrane fluidity changes and calcium ion transport are dealt with, then the role of amyloid inhibitors and A-sheet breaking drugs is included. The likely important beneficial effects of the cholesterol-lowering drugs, the statins, in lowering brain AA and consequently the therapeutic prevention of AD by reducing AA deposition in plaquesis discussed thoroughly. Finally, an exciting new concept is advanced, namely the possible significance of phosphorylated AA in Alzheimera (TM)s disease. From in vitro experiments AA phosphorylation appears to increase the proportion of AA oligomeric forms, an observation which correlates with a the higher cytotoxicity of this species, compared to non-phosphorylated AA.

The editors hope that this book will be of interest and value to both medical and scientific research communities working on AD, and to others with a more general interest in the understanding of this devastating neurodegenerative disorder of the elderly.

Prof. J. Robin Harris

Prof. Falk Fahrenholz

University of Mainz

August, 2004

This book constitutes a clear, comprehensive, up-to-date introduction to the basic principles of psychological and educational assessment that underlie effective clinical decisions about childhood language disorders. Rebecca McCauley describes specific commonly used tools, as well as general approaches ranging from traditional standardized norm-referenced testing to more recent ones, such as dynamic and qualitative assessment. Highlighting special considerations in testing and expected patterns of performance, she reviews the challenges presented by children with a variety of problems--specific language impairment, hearing loss, mental retardation, and autism spectrum disorders. Three extended case examples illustrate her discussion of each of these target groups. Her overarching theme is the crucial role of well-formed questions as fundamental guides to decision making, independent of approach.
Each chapter features lists of key concepts and terms, study questions, and recommended readings. Tables throughout offer succinct summaries and aids to memory.
Students, their instructors, and speech-language pathologists continuing their professional education will all welcome this invaluable new resource.
Distinctive features include:
* a comprehensive consideration of both psychometric and descriptive approaches to the characterization of children's language;
* a detailed discussion of background issues important in the language assessment of the "major" groups of children with language impairment;
* timely information on assessment of change--a topic frequently not covered in other texts;
* extensive guidance on how to evaluate individualnorm-referenced measures for adoption;
* an extensive appendix listing about 50 measures used to assess language in children; and
* a test review guide that can be reproduced for use by readers.

Even if the "weapons of mass destruction" (WMD) and, among them, stocks of organoph- phorus (OP) agents (also referred to as war gases and nerve gases) were not found in Iraq following the US-Iraq war, the relative ease with which these substances can be made from harmless precursors and the low cost of their manufacture will continue to fascinate pow- hungry, ruthless dictators, as well as multinational and international terrorists, particularly as the close relationship between the OP agents and useful insecticides makes it easy to disguise the importation and purchase of small amounts of the precursors. Indeed, the use by Saddam Hussein of a nerve gas against the Kurds and his possible employment of the OP agents during his war with Iran, and the Sarin attack in the Tokyo underground by an extremist religious set magnetized the world with respect to the OP drugs. As these drugs exert their toxicity via their cholinergic action on the nervous, particularly central nervous, system, it is no wonder that the research in the cholinergic ? eld attracts, and merits, our intense attention. These considerations underlie the signi? cance of this book, as Alex Karczmar devotes an entire chapter of Exploring the Vertebrate Central Cholinergic Nervous System to anticholinest- ases (antiChEs), and as he is an acknowledged expert in the ? eld of cholinergic toxicity as well as a consultant to the Surgeon General of the U. S. Army.

Metabotropic Glutamate Receptors in Psychiatric and Neurological Disorders, Volume 168 in the International Review of Neurobiology series, highlights advances in the field, with this new volume presenting interesting chapters on topics such as mGlu receptors in Parkinson's disease, Metabotropic glutamate receptors in estradiol-mediated motivated behaviors in females, mGlu regulation of sleep, Implications for sleep disruptions in psychiatric disorders, Mechanisms of mGlu receptor trafficking; alterations by methamphetamine, Group I mGlu and cocaine seeking, The role of mGlu receptors in fear and anxiety, Regulation of Alcohol Consumption, Reward, Dependence, and Perception by Metabotropic Glutamate Receptor Signaling, and mGlu5 as a biomarker for psychiatric disorders.

Learn to handle the problems that Parkinson's patients face
Through Parkinson's Disease and Quality of Life, you will discover common problem areas seen in patients with Parkinson's disease. This book explores problems that interfere with functional independence of patients and gives examples of occupational therapy intervention and treatment techniques. Parkinson's Disease and Quality of Life boldly deals with many seldom talked about real-life issues facing people with Parkinson's disease, including continued sexual intimacy and urinary incontinence. Although these issues may not be curable, this book provides you with effective treatments through data and case studies.
Parkinson's Disease and Quality of Life offers caregivers a step-by-step plan to get organized. It includes a plan to put together a workbook of all relevant information, as well as tips on how to safeguard every room for a Parkinson's disease patient. This book helps remind you that the families of the patient must not be forgotten and that they can get the help they need through support groups, community resources, and from professional staffing such as nurses and aides. Parkinson's Disease and Quality of Life will assist you in helping your patients by:

• using music therapy to help calm patients
• realizing the legal impact of Parkinson's disease by discussing living wills, health care proxies, durable power of attorney, and revocable and irrevocable trusts with your clients
• discovering that cognitive changes, dementia, and depression can complicate the treatment of the disease and be more disabling than the loss of motor function
• exploring the nursing home as a viable options for clients as well as their families

Dale's Principle postulated that a neuron functions as a metabolic unit, whereby a process occurring in the cell can influence all of the compartments of that given neuron. This was unfortunately transformed in the literature to a principle stating that a single cell releases only one neurotransmitter . Until recently, this has influenced many neuroscientists to consider with skepticism the idea that classical neurotransmitters could be co-released from neurons.

It is now clear that the one neuron, one neurotransmitter postulate is the exception rather than the rule. The aim of this book is to gather the available evidence, provided by the authors that have discovered and studied the co-existence or co-release of several pairs of neurotransmitters, in several neural networks. It will provide a timely overview of a mechanism of neural communication that is likely to attract increasing attention of the neuroscientific community.

Most brain related activity has focussed on specialized interests within individual disciplines. Recent multidisciplinary activity has provided the impetus to break down these boundaries and encourage a freer exchange of information across disciplines. This text reflects these developments. It spans the landscape of brain science to provide core information from 12 disciplines (including evolution, philosophy, anatomy, chemistry, computer science, brain dynamics, psychology, neurology, psychiatry, psychotherapy and brain imaging).
In outlining how and why it is now possible to realistically model aspects of the brain's dynamics from such a wide range of intellectual endeavors, this book will prove itself useful to undergraduates, postgraduates and all those seeking a contemporary perspective and evaluation of the current status and future directions in the brain sciences.

Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnetic resonance imaging and spectroscopy are detailed for diagnosing this solid, extracranial cancer. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer. Ornithine decarboxylase and polyamines are novel targets for therapeutic intervention. The effectiveness of chemotherapy with oral irinotecan and temozolomide is explained. The role of transcription factors (GATA) in neuroblastoma pregression is also included.

Cerebral visual disorders have far-reaching consequences for child development. These have profound adverse effects on children's education and success in school and also in later life, but, unfortunately, cerebral visual disorders often remain undiagnosed and untreated in the pediatric population. This book provides a state-of-the-art account of what is known about the development and disorders of visual perception in children. It covers the development and disorders of visual perception in children, their assessment, early intervention and management in an interdisciplinary context, both from a scientific as well as clinical perspective. Case studies illustrate the recommended assessment and rehabilitation procedures; synopses, boxes and check-lists complement the presentation of our recommendations for clinical practice.

About 40% of central nervous system synapses use glutamate as the neurotransmitter. Over-stimulation of glutamate receptors produces neuronal injury or death by excitotoxicity, which is closely associated with neurochemical and neuropathological changes involved in acute neural trauma (stroke, spinal cord trauma, and head injury) and neurodegenerative diseases such as Alzheimer disease, Parkinson disease, Huntington disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt-Jakob disease, Guam-type amyotrophic lateral sclerosis/Parkinson dementia (ALS/PDC), and multiple sclerosis.

In the past decade, our understanding of the biochemistry, molecular biology, and neuropathology of the glutamate transporters and receptors has exploded. It is becoming increasingly evident that molecular mechanisms, which govern the transfer of the death signal from the neural cell surface to the nucleus, depend on lipid mediators and on cross talk among excitotoxicity, oxidative stress, and neuroinflammation, and that interactions among these three processes play a major role in neuronal cell death during acute neural trauma and neurodegenerative disease. These processes may be primary initiating points in neurodegeneration or they may be the end result of the neurodegenerative process itself.

Neurochemical Aspects of Excitotoxicity provides extensive insight into glutamate transporters and receptors, including their role in the brain with other neurochemical parameters in excitotoxicity, and possible treatments. This book will be of interest scientists already working in the field of excitotoxicity who are interested in gaining a broader understanding of this complicated subject area, aswell as graduate students and neurologists who are curious about a common cause of neuronal injury and neurological disorders.

When I first proposed this book, one of the hopes was that it would be the stage upon which would be conducted a quiet, well reasoned discussion of the various techniques of stereotactic radio surgery. At that time, there was quite a bit of rancorous debate that tended to obscure the scientific and medical merits of each of the separate methods. At the present time, I am happy to report that the field of stereotactic radiosurgery is much less riven by such inappropriate posturing. The field has taken many steps towards maturity, both technically and medically. In the course of this mat uration process, there have been many grandiose plans and speeches made on behalf of stereotactic radiosurgery. Inevitably, the reality will not live up to the hype, but such is the natural course of devel opment in these sorts of matters. However, even though events may not match our hopes, we should keep in mind the words of Herbert Parker. Recognizing that new modalities for the treatment of cancer do not stand much chance of revolutionary success, nevertheless, he quite correctly pointed out that " . . . with any type of radiatiQn, the margin between success and failure is small. If the chance of success is a little greater . . . thi might well be classed as a great advance. " Mark H."

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

1) Classic anatomical atlases 2) Detailed labeling of the earliest phases of prenatal neorological development 3) Appeals to neuroanatomists, developmental biologists and clinical practioners. 4) Persistent relevantce - brain development is not going to change.

With a focus on practical acute pain management in adults in the hospital setting, this book provides health professionals with simple and practical information to help them manage patients with acute pain safely and effectively. * Combines evidence-based information with practical guidelines and protocols * Covers the pharmacology of opioids, local anesthetics, and nonopioid and adjuvant analgesic agents * Discusses management of acute pain in both surgical and nonsurgical acute pain settings including in patients with spinal cord or burns injuries and selected medical illnesses * Includes evidence-based information about management of acute pain in some specific patient groups , including the older patient, opioid-tolerant patients, and those with addiction disorders, pregnant or lactating patients and patients with obstructive sleep apnea or who have renal or hepatic impairment * Considers the role of acute pain management in the context of the current opioid epidemic and identifies possible strategies to minimise the risks. This resource will be helpful to a variety of professionals in assessing and managing acute pain.

Cortical Functions is a companion to Kevin Silber's series title, The Physiological Basis of Behaviour and concentrates on the cerebral cortex, its structure, connections, functions and dysfunctions. John Stirling includes clinical descriptions and case studies to illustrate various forms of agnosia, aphasia, amnesia and the split brain syndrome. Methods in neuropsychology are reviewed and other chapters provide comprehensive but straightforward coverage of the role of the brain in language, sensation, perception and movement.

Related link: A-Level Psychology Website
Related link: Availalbe for Inspection
Related link: Free Email Alerting

Understanding Young Onset Dementia provides a state-of-the-art overview of approaches to care and evaluation for people with young onset dementia. It reviews the challenges in providing care and services, outlines new innovations in treatment and explores the impact of the condition to offer guidance about best practice in care. Written by world-leading researchers and experts in the field, this book gives key evidence for best practice and focuses on lived experience of those with young onset dementia. It has a broad focus looking at aspects of care beyond diagnosis and gives a comprehensive summary of the current qualitative and quantitative research in the field of young onset dementia. This international collaboration fills a much-needed gap in the academic market and is vital to guide learning and deliver future innovations. This book will be of great interest for academics, scholars and post graduate students in the field of mental health and dementia research. It will also appeal to neurologists, psychiatrist, geriatricians and psychologists looking to update their knowledge or already working in the field.

From the 19th Collegium Internationale Neuro-psychopharmacolgicum (CINP) Congress in 1994 comes this long-awaited collection that explores traditional herbal medicines as they relate to the treatment of neuropsychiatric diseases today. Dr. Shigenobu Hanba, co-chair of the symposium, joins together with co-editor Dr. Elliot Richelson and other distinguished scientists from around the world to discuss the role that age-old medicinals can play in modern-day therapy. For clinical and basic scientists alike, Herbal Medicines for Neuropsychiatric Disorders provides a comprehensive overview of the status of traditional herbal medicines as they relate to the treatment of neurospychiatric diseases. It will also serve as a source for detailed information on specific natural products and their constituents, as well as a reference point from which to begin a more in-depth exploration of this fascinating field.
Eastern cultures have been using herbal medicines for centuries and mainstream practitioners in many countries continue to use them as valid and effective forms of therapy for neuropsychiatric disorders. An important exception in Western culture, of course, is the United States, where governmental standards for safety and efficacy often pose obstacles for the speedy approval of drugs based on what some might label folkloric remedies. However, in the U.S. today, scientists are now conducting research with traditional herbal medicines with the belief that they offer enormous possibilities for the discovery of new drugs that would provide the basis of a new and effective psychopharmacology.
Along with detailed information on this research, the readers of Herbal Medicines for Neuropsychiatric Disorders explore ancient cultures to gain a greater perspective on the herbal medicines of Japan, China and India. Further reading offers chemical and pharmacological studies of various herbal medicines, as well as reports of studies in which behavioral and biochemical effects of various herbal preparations were tested on senescence-acclerated mice.